DUBLIN, Aug. 28, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/r4hwkk/investigation) has announced the addition of the "Investigation Report on China's Pranoprofen Market, 2010-2019" report to their offering.

Originally discovered by Welfide (Mitsubishi Tanabe Pharma Corporation formerly known as Yoshitomi Pharmaceutical Industries, Ltd) as an inflammatory drug, pranoprofen was later developed into eye drop by Senju Pharmaceutical Co., Ltd under the trade name of pranopulin for the treatment of inflammation of outer eye or anterior segment of the eye like blepharitis, conjunctivitis and keratitis. In 1999, pranoprofen eye drops was approved by the CFDA to enter the Chinese market for clinical use, followed by product from Shandong Haishan Pharmaceutical Co., Ltd and Guangzhou Kangqiao Hanpu Pharmaceutical Co., Ltd in 2009 and product of in 2013.
Pranoprofen developed fast after entering China, with sales value rising from CNY 64.04 million in 2013 to CNY 74.39 million in 2014 with a year-on-year growth of 16.2% and CAGR during the period of 2010-2014 reaching 38.7%.

As computer pervades into work and life, the incidence of eye disease keeps rising, which leads to the vast demand for pranoprofen in China. Currently, pranoprofen in the Chinese market mainly come from the following three enterprises: Senju Pharmaceutical Co., Ltd, Shandong Haishan Pharmaceutical Co., Ltd and Guangzhou Kangqiao Hanpu Pharmaceutical Co., Ltd, among which Senju Pharmaceutical Co.,Ltd had the largest market share of 89.38% which dropped from 90.59% in 2013 due to Shandong Haishan Pharmaceutical Co., Ltd and Guangzhou Kangqiao Hanpu Pharmaceutical Co., Ltd's entering into the market with sales reaching CNY 66.49 million in 2014. Domestic drugs are expected to occupy an increasingly large share in the next few years.

Key Topics Covered:

1 Related Concepts of Pranoprofen

2 Market Profile of Pranoprofen in China

3 Survey of Pranoprofen Sales in China, 2010-2014

4 Survey of Major Pranoprofen Manufacturers' Market Share in China, 2010-2014

5 Survey of Dosage Forms of Pranoprofen in China, 2010-2014

6 Reference Price of Pranoprofen in Chinese Hospitals in 2014

7 Major Manufacturers of Pranoprofen in Chinese Market, 2010-2014

8 Market Outlook of Pranoprofen in China, 2015-2019

Companies Mentioned

- Guangzhou Kangqiao Hanpu Pharmaceutical Co., Ltd
- Senju Pharmaceutical Co., Ltd
- Shandong Haishan Pharmaceutical Co., Ltd

For more information visit http://www.researchandmarkets.com/research/r4hwkk/investigation

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net

Related Links

http://www.researchandmarkets.com

SOURCE Research and Markets